| Fonds | 2025/Q4 | 2025/Q3 | ||||
|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 62.442.251 $ | +20.033.069 $ | +506,6 % | 45.065.424 $ | +9.772.117 $ | +36,4 % | |
| BVF INC/IL | 26.867.360 $ | +8.680.224 $ | +47,7 % | 18.187.136 $ | +3.823.432 $ | +26,6 % |
| Blue Owl Capital Holdings LP | 8.953.513 $ | +2.892.673 $ | +47,7 % | 6.060.840 $ | +1.274.154 $ | +26,6 % |
| ORBIMED ADVISORS LLC | 8.638.469 $ | +2.790.890 $ | +47,7 % | 5.847.579 $ | +1.229.321 $ | +26,6 % |
| Versant Venture Management, LLC | 4.658.116 $ | +979.263 $ | +26,6 % | |||
| Redmile Group, LLC | 4.124.052 $ | +1.332.386 $ | +47,7 % | 2.791.666 $ | +586.884 $ | +26,6 % |
| Rangeley Capital, LLC | 3.348.355 $ | +2.211.613 $ | +194,6 % | 1.136.742 $ | +642.886 $ | +130,2 % |
| MARSHALL WACE, LLP | 2.900.935 $ | |||||
| RENAISSANCE TECHNOLOGIES LLC | 2.551.536 $ | +1.277.014 $ | +100,2 % | 1.274.522 $ | +547.748 $ | +75,4 % |
| MPM ASSET MANAGEMENT LLC | 1.973.520 $ | +414.888 $ | +26,6 % | |||
| MPM BioImpact LLC | 1.443.066 $ | +303.372 $ | +26,6 % | |||
| CITADEL ADVISORS LLC | 663.811 $ | -566.952 $ | -46,1 % | 1.230.763 $ | -93.751 $ | -7,1 % |
| JANE STREET GROUP, LLC | 967.210 $ | |||||
| TWO SIGMA INVESTMENTS, LP | 867.604 $ | +848.302 $ | +4.394,9 % | |||
| Yakira Capital Management, Inc. | 693.162 $ | |||||
| NORTHERN TRUST CORP | 676.809 $ | +215.335 $ | +46,7 % | 461.474 $ | +63.920 $ | +16,1 % |
| EQUITEC PROPRIETARY MARKETS, LLC | 647.595 $ | |||||
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 541.840 $ | +351.584 $ | +184,8 % | |||
| 62.442.251 $ | +20.033.069 $ | +506,6 % | 45.065.424 $ | +9.772.117 $ | +36,4 % | |